

share
Barixibat CAS NO 263562-28-3
Unit Price:
CAS No.:263562-28-3
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Barixibat is a potent and selective inhibitor of the apical sodium-dependent bile acid transporter (ASBT), designed to modulate bile acid reabsorption in the ileum. This mechanism of action makes it a critical compound for research and development in the treatment of chronic cholestatic liver diseases and related metabolic disorders. It is primarily utilized by pharmaceutical R&D teams, contract research organizations (CROs), and academic institutions focused on hepatology and gastroenterology.
Application
- Pharmaceutical research and development for cholestatic liver diseases (e.g., Primary Biliary Cholangitis, Alagille Syndrome).
- Investigational studies targeting pruritus (itching) associated with chronic liver conditions.
- Preclinical and clinical development of novel metabolic disorder therapeutics.
- Biochemical research on bile acid metabolism and enterohepatic circulation pathways.
- Reference standard for analytical method development and quality control in API manufacturing.
- Pharmacology studies to understand ASBT inhibition and its systemic effects.
Basic Information
| Product Name | Barixibat |
| CAS No. | 263562-28-3 |
| Molecular Formula | C29H41N3O6S |
| Molecular Weight | 559.72 g/mol |
| Synonyms | 1-[4-[[4-[(4R,5R)-3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]cyclopentanecarboxylic acid; SD-5613; A-3309; Barixibat sodium; GSK-2330672; ASBT Inhibitor |
| EINECS | Contact for details |
Quality Control
Our Barixibat CAS NO 263562-28-3 is manufactured under strict quality systems to ensure high purity and batch-to-batch consistency, suitable for research and development purposes. Each batch is supported by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We adhere to cGMP guidelines where applicable to support our clients' regulatory requirements.
Storage
Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a dry environment. The product is hygroscopic (moisture-sensitive) and should be handled under anhydrous conditions to maintain stability.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white powder |
| Identification (IR) | Conforms to structure |
| Identification (HPLC) | Retention time matches reference standard |
| Assay (HPLC) | ≥98.0% |
| Related Substances (HPLC) | Total impurities ≤2.0% Any single unknown impurity ≤0.5% |
| Water Content (KF) | ≤1.0% |
| Residue on Ignition | ≤0.1% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Tauroursodeoxycholic Acid CAS NO 14605-22-2


Berberine Hydrochloride CAS NO 633-65-8


Ursodeoxycholic Acid CAS NO 128-13-2


Sirepar CAS NO 11095-03-7


Tiopronin CAS NO 1953-02-2


Hemulcholic Acid CAS NO 14959-83-2


Citiolone CAS NO 17896-21-8


Ademethionine 1,4-Butanedisulfonate CAS NO 101020-79-5


Homoursodeoxycholic Acid CAS NO 102044-28-0


Allo-Udca CAS NO 105227-28-9


Phocaecholic Acid CAS NO 105369-89-9


23-Methylursodeoxycholic Acid CAS NO 113301-20-5


Tauroursodeoxycholate Dihydrate CAS NO 117609-50-4


3,6-Dihydroxy-6-Methylcholanoic Acid CAS NO 123202-27-7


Tauret CAS NO 133867-05-7


Cifaop CAS NO 142223-44-7


7-Sulfo-Ursodeoxycholic Acid Disodium Salt CAS NO 191286-16-5


Int-767 CAS NO 1000403-03-1


Ademetionine 1,4-Butanedisulfonate CAS NO 1014692-62-6


Ademetionine CAS NO 1253909-57-7
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






